Supplement encyclopedia

Bacopa monnieri

Bacopa monnieri is a herbaceous plant eaten as a leafy green and used to make supplements. Capsules may contain powdered plant material or extracts that vary in composition and in how they are standardized.

Double-check the conclusions and review the sources before choosing a supplement.

Main conclusion

Potential benefits

  • In adults with recently developed stress, B-Lit extract reduced perceived stress and improved questionnaire-rated emotional well-being more than placebo over 12 weeks.
  • In the same group, sleep ratings improved more with B-Lit than with placebo over 12 weeks. In another trial in adults with poor sleep, Bacognize extract showed no advantage in the insomnia score over 27 days.
  • In healthy adults aged 18–55 without sleep disorders, B-Lit improved performance on a digit-sequence memory task over 12 weeks: the average gain was 2.45 points versus 0.17 with placebo.
  • In adults aged 40–70 with memory and attention complaints, Bacumen showed no advantage over placebo in the primary word-memory and attention tasks over 12 weeks.
  • In the same group, Bacumen reduced overall questionnaire-rated stress sensitivity more than placebo over 12 weeks. After a series of tasks, participants taking Bacumen also reported less mental fatigue than those on placebo.

[1] [2] [3] [4] [5]

What researchers studied

  • In adults complaining of poor sleep, questionnaire-rated emotional well-being improved more with Bacognize than with placebo over 27 days.
  • In healthy adults without sleep disorders, sleep ratings also improved more with B-Lit than with placebo over 12 weeks.
  • Bacopa may cause nausea, abdominal pain, and diarrhea. In the Bacumen study, digestive complaints and headache occurred more often than with placebo.

[1] [2] [3] [4]

Forms studied

  • In the studies, B-Lit was taken at 300 mg of extract daily; it contained 30% bacosides, or 90 mg. Look for the extract name and the amount of extract itself per serving on the package.
  • Bacumen was studied at 150 mg twice daily for 12 weeks. Bacognize, a whole-plant extract with 12% bacopa glycosides, was used at 150 mg twice daily for 27 days.
  • The study in people aged 65 and over used 300 mg of MediHerb aerial-parts extract with at least 50% bacosides A and B. When comparing products, consider which substances were measured and by which method.
  • The name “brahmi” is also used for a different plant, Centella asiatica. Check the Latin name Bacopa monnieri on the label.

[1] [2] [3] [4] [5] [6] [7]

Food sources

  • In some parts of India, bacopa is used as a leafy green.
  • Dried bacopa powder has been studied as an ingredient in flatbreads, soups, and sandwiches. These dishes and the concentrated extracts studied differ in composition.

[1] [2]

Effects and studied questions

How to read the certainty scale 1–4

Certainty is rated separately for each outcome. 1 is very low, 2 is low, 3 is moderate and 4 is high.

Goal or questionResultConfidenceStudiesPopulation studiedKey sources
Digit recall — B-LitOn the Digit Span test of digit sequence recall, scores rose by an average of 2.45 points with B-Lit and 0.17 points with placebo over 84 days. The difference in change was 2.28 points.
2/4 LowRisk of bias. The analysis included only participants who completed the study. Several participants dropped out. The researchers assessed many outcomes. Replication. One trial is presented for this comparison. Studies of other extracts do not replicate this trial. Applicability. The study measured performance on specific tests. It did not measure overall performance at school, at work, or in everyday activities. Precision. The sample was small, limiting the precision of the between-group difference. Completeness of publication. One trial is insufficient to assess whether negative results went unpublished.
1randomized trialEffect of Bacopa monnieri Extract on Memory and Cognitive Skills in Adult Humans: A Randomized, Double-Blind, Placebo-Controlled Study ↗Healthy adults aged 18–55 without sleep disorders. 80 were assigned to groups and 74 completed the study (38 in the B-Lit group and 36 in the placebo group).
  1. Effect of Bacopa monnieri Extract on Memory and Cognitive Skills in Adult Humans: A Randomized, Double-Blind, Placebo-Controlled Study ↗
Delayed word recall in older adultsAfter 12 weeks, participants recalled an average of 7.6 words after a delay, up from 6.4 at baseline with bacopa, and 6.9 words, up from 6.8 with placebo. The paper tested changes statistically within each group and did not report a separate estimate of the difference in change between groups.
2/4 LowRisk of bias. The study was small, with 48 of 54 participants completing it. For this outcome, the authors tested change within each group, limiting what can be concluded about a benefit over placebo. Replication. One trial is presented for this comparison. Studies of other extracts do not replicate this trial. Applicability. The study measured performance on specific tests. It did not measure overall performance at school, at work, or in everyday activities. Precision. The sample was small, limiting the precision of the between-group difference. Completeness of publication. One trial is insufficient to assess whether negative results went unpublished.
1randomized trialEffects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial ↗Independently living adults aged 65 and older without dementia or memory complaints. 54 were assigned to groups and 48 completed the study (24 per group).
  1. Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial ↗
Word learning and recall — BacumenOn the primary test of word learning and recall, Bacumen showed no benefit over placebo after 12 weeks (p=0.391).
2/4 LowRisk of bias. The analysis included the 87 of 101 participants who completed the study. Dropout differed between groups (10 with Bacumen and 4 with placebo). Replication. One trial is presented for this comparison. Studies of other extracts do not replicate this trial. Applicability. The study measured performance on specific tests. It did not measure overall performance at school, at work, or in everyday activities. Precision. The sample was small, limiting the precision of the between-group difference. Completeness of publication. One trial is insufficient to assess whether negative results went unpublished.
1randomized trialThe Effects of a Bacopa monnieri Extract (Bacumen®) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial ↗Adults aged 40–70 with memory and attention complaints. 101 were assigned to groups and 87 completed the study (40 in the Bacumen group and 47 in the placebo group).
  1. The Effects of a Bacopa monnieri Extract (Bacumen®) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial ↗
  2. An examination into the effects of a Bacopa monnieri extract (Bacumen) on cognition and stress in healthy adults with subjective memory complaints: a randomised, double-blind, placebo-controlled trial — ANZCTR ACTRN12623000475640 ↗

The study count refers to the cited source. Reviews with overlapping trials and outcomes from one study are not added together.

Forms

Extract composition. The weight of a capsule differs from the weight of the extract it contains. When comparing labels, check the extract name, the amount it contains, and how the bacosides were measured. Matching milligram amounts or percentages alone do not establish that the composition is the same. B-Lit. Two studies used 300 mg of extract containing 30% bacosides, equivalent to 90 mg of bacosides per day. Participants took one capsule in the morning after breakfast for 84 days. In the stress study, the whole capsule weighed 500 mg and contained 300 mg of extract and 200 mg of filler. MediHerb. In the study of older adults, participants took one tablet per day containing 300 mg of dry extract from the above-ground parts of the plant. The extract was reported to contain at least 50% bacosides A and B, measured by spectrophotometry, which measures how much light a sample absorbs. Bacumen. The study tested 300 mg of extract per day for 12 weeks. The trial registration specifies 150 mg capsules taken twice daily with food. Bacognize. The sleep study used a whole-plant extract made with water and alcohol, taken as 150 mg in the morning and 150 mg in the evening, with or without food. The extract was reported to contain 12% bacopa glycosides as measured by HPLC, a method that separates and measures the components of a mixture. Participants took it for 27 days during the 28-day study. Name on the label. The name “brahmi” is used for both Bacopa monnieri and another plant, Centella asiatica (gotu kola). Check the plant's Latin name.

Guidance for each goal

Digit recall — B-Lit2/4 LowRead moreCollapse
Confidence
2/4 LowRisk of bias. The analysis included only participants who completed the study. Several participants dropped out. The researchers assessed many outcomes. Replication. One trial is presented for this comparison. Studies of other extracts do not replicate this trial. Applicability. The study measured performance on specific tests. It did not measure overall performance at school, at work, or in everyday activities. Precision. The sample was small, limiting the precision of the between-group difference. Completeness of publication. One trial is insufficient to assess whether negative results went unpublished.

On the Digit Span test of digit sequence recall, scores rose by an average of 2.45 points with B-Lit and 0.17 points with placebo over 84 days. The difference in change was 2.28 points.

Study findings. On the Digit Span test of digit sequence recall, scores rose by an average of 2.45 points with B-Lit and 0.17 points with placebo over 84 days. The difference in change was 2.28 points.

Studied regimen300 mg of extract per day, taken as 1 capsule in the morning after breakfastB-Lit capsule containing 300 mg of extract and 90 mg of bacosides
Duration and population84 daysHealthy adults aged 18–55 without sleep disorders. 80 were assigned to groups and 74 completed the study (38 in the B-Lit group and 36 in the placebo group).

Comparator — placebo capsule containing microcrystalline cellulose

Delayed word recall in older adults2/4 LowRead moreCollapse
Confidence
2/4 LowRisk of bias. The study was small, with 48 of 54 participants completing it. For this outcome, the authors tested change within each group, limiting what can be concluded about a benefit over placebo. Replication. One trial is presented for this comparison. Studies of other extracts do not replicate this trial. Applicability. The study measured performance on specific tests. It did not measure overall performance at school, at work, or in everyday activities. Precision. The sample was small, limiting the precision of the between-group difference. Completeness of publication. One trial is insufficient to assess whether negative results went unpublished.

After 12 weeks, participants recalled an average of 7.6 words after a delay, up from 6.4 at baseline with bacopa, and 6.9 words, up from 6.8 with placebo. The paper tested changes statistically within each group and did not report a separate estimate of the difference in change between groups.

Study findings. After 12 weeks, participants recalled an average of 7.6 words after a delay, up from 6.4 at baseline with bacopa, and 6.9 words, up from 6.8 with placebo. The paper tested changes statistically within each group and did not report a separate estimate of the difference in change between groups.

Studied regimen300 mg of extract per day, taken as 1 tabletMediHerb tablet containing an extract of the above-ground parts of bacopa, with at least 50% bacosides A and B as measured by the study's method
Duration and population12 weeks of treatment after a 6-week placebo run-inIndependently living adults aged 65 and older without dementia or memory complaints. 54 were assigned to groups and 48 completed the study (24 per group).

Comparator — tablets without extract, matched for appearance, smell, and texture

Word learning and recall — Bacumen2/4 LowRead moreCollapse
Confidence
2/4 LowRisk of bias. The analysis included the 87 of 101 participants who completed the study. Dropout differed between groups (10 with Bacumen and 4 with placebo). Replication. One trial is presented for this comparison. Studies of other extracts do not replicate this trial. Applicability. The study measured performance on specific tests. It did not measure overall performance at school, at work, or in everyday activities. Precision. The sample was small, limiting the precision of the between-group difference. Completeness of publication. One trial is insufficient to assess whether negative results went unpublished.

On the primary test of word learning and recall, Bacumen showed no benefit over placebo after 12 weeks (p=0.391).

Study findings. On the primary test of word learning and recall, Bacumen showed no benefit over placebo after 12 weeks (p=0.391).

Studied regimen300 mg of extract per day, taken as 150 mg twice daily with foodBacumen extract in capsules
Duration and population12 weeksAdults aged 40–70 with memory and attention complaints. 101 were assigned to groups and 87 completed the study (40 in the Bacumen group and 47 in the placebo group).

Comparator — placebo capsules containing microcrystalline cellulose, matched for appearance and taste

Attention — Bacumen2/4 LowRead moreCollapse
Confidence
2/4 LowRisk of bias. The analysis included the 87 of 101 participants who completed the study. Dropout differed between groups (10 with Bacumen and 4 with placebo). Replication. One trial is presented for this comparison. Studies of other extracts do not replicate this trial. Applicability. The study measured performance on specific tests. It did not measure overall performance at school, at work, or in everyday activities. Precision. The sample was small, limiting the precision of the between-group difference. Completeness of publication. One trial is insufficient to assess whether negative results went unpublished.

On the primary attention test, Bacumen showed no benefit over placebo after 12 weeks (p=0.713).

Study findings. On the primary attention test, Bacumen showed no benefit over placebo after 12 weeks (p=0.713).

Studied regimen300 mg of extract per day, taken as 150 mg twice daily with foodBacumen extract in capsules
Duration and population12 weeksAdults aged 40–70 with memory and attention complaints. 101 were assigned to groups and 87 completed the study (40 in the Bacumen group and 47 in the placebo group).

Comparator — placebo capsules containing microcrystalline cellulose, matched for appearance and taste

Performance on a task with distracting information in older adults2/4 LowRead moreCollapse
Confidence
2/4 LowRisk of bias. The study was small, with 48 of 54 participants completing it. For this outcome, the authors tested change within each group, limiting what can be concluded about a benefit over placebo. Replication. One trial is presented for this comparison. Studies of other extracts do not replicate this trial. Applicability. The study measured performance on specific tests. It did not measure overall performance at school, at work, or in everyday activities. Precision. The sample was small, limiting the precision of the between-group difference. Completeness of publication. One trial is insufficient to assess whether negative results went unpublished.

On the Stroop test, reaction time decreased from 60.1 to 57.2 seconds with bacopa and from 60.9 to 60.5 seconds with placebo. A shorter time means faster performance on the task with distracting information. The statistical test in the paper assessed change within the group.

Study findings. On the Stroop test, reaction time decreased from 60.1 to 57.2 seconds with bacopa and from 60.9 to 60.5 seconds with placebo. A shorter time means faster performance on the task with distracting information. The statistical test in the paper assessed change within the group.

Studied regimen300 mg of extract per day, taken as 1 tabletMediHerb tablet containing an extract of the above-ground parts of bacopa, with at least 50% bacosides A and B as measured by the study's method
Duration and population12 weeks of treatment after a 6-week placebo run-inIndependently living adults aged 65 and older without dementia or memory complaints. 54 were assigned to groups and 48 completed the study (24 per group).

Comparator — tablets without extract, matched for appearance, smell, and texture

Perceived stress — B-Lit2/4 LowRead moreCollapse
Confidence
2/4 LowRisk of bias. The analysis included only participants who completed the study. Several participants dropped out. The researchers assessed many outcomes. Replication. One trial is presented for this comparison. Studies of other extracts do not replicate this trial. Applicability. The result applies to the specified extract, population, and task. Precision. The sample was small, limiting the precision of the between-group difference. Completeness of publication. One trial is insufficient to assess whether negative results went unpublished.

Over 84 days, the PSS-10 perceived stress score decreased by an average of 6.30 points with B-Lit and 0.38 points with placebo. The difference in change was 5.92 points in favor of B-Lit.

Study findings. Over 84 days, the PSS-10 perceived stress score decreased by an average of 6.30 points with B-Lit and 0.38 points with placebo. The difference in change was 5.92 points in favor of B-Lit.

Studied regimen300 mg of extract per day, taken as 1 capsule in the morning after breakfastB-Lit capsule containing 300 mg of extract standardized to 30% bacosides
Duration and population84 daysAdults aged 18–60 who had experienced stress for no more than 12 weeks and had no psychiatric diagnosis. 50 were assigned to groups and 44 completed the study (23 in the B-Lit group and 21 in the placebo group).

Comparator — placebo capsule containing 500 mg of microcrystalline cellulose

Overall stress reactivity — Bacumen2/4 LowRead moreCollapse
Confidence
2/4 LowRisk of bias. The analysis included the 87 of 101 participants who completed the study. Dropout differed between groups (10 with Bacumen and 4 with placebo). Replication. One trial is presented for this comparison. Studies of other extracts do not replicate this trial. Applicability. Overall stress reactivity was measured by questionnaire in people with memory and attention complaints. Precision. The sample was small, limiting the precision of the between-group difference. Completeness of publication. One trial is insufficient to assess whether negative results went unpublished.

Over 12 weeks, participants taking Bacumen reported a greater decrease in overall stress reactivity than those taking placebo (p=0.03). This result came from the Perceived Stress Reactivity Scale questionnaire, which was separate from the assessment of responses to computer tasks.

Study findings. Over 12 weeks, participants taking Bacumen reported a greater decrease in overall stress reactivity than those taking placebo (p=0.03). This result came from the Perceived Stress Reactivity Scale questionnaire, which was separate from the assessment of responses to computer tasks.

Studied regimen300 mg of extract per day, taken as 150 mg twice daily with foodBacumen extract in capsules
Duration and population12 weeksAdults aged 40–70 with memory and attention complaints. 101 were assigned to groups and 87 completed the study (40 in the Bacumen group and 47 in the placebo group).

Comparator — placebo capsules containing microcrystalline cellulose, matched for appearance and taste

Fatigue after mental tasks — Bacumen2/4 LowRead moreCollapse
Confidence
2/4 LowRisk of bias. The analysis included the 87 of 101 participants who completed the study. Dropout differed between groups (10 with Bacumen and 4 with placebo). Replication. One trial is presented for this comparison. Studies of other extracts do not replicate this trial. Applicability. Researchers measured fatigue after a series of mental tasks in people with memory and attention complaints. The result does not describe alertness throughout the day. Precision. The sample was small, limiting the precision of the between-group difference. The means shown are rounded estimates from the graph. They were not taken from a table of numerical results. Completeness of publication. One trial is insufficient to assess whether negative results went unpublished.

The authors reported less fatigue after a series of mental tasks with Bacumen. In the published graph, mental fatigue immediately after a computer task at week 12 was about 28 points with Bacumen and 33 with placebo, compared with about 30 and 27 points, respectively, before treatment. The values are rounded estimates from the graph.

Study findings. The authors reported less fatigue after a series of mental tasks with Bacumen. In the published graph, mental fatigue immediately after a computer task at week 12 was about 28 points with Bacumen and 33 with placebo, compared with about 30 and 27 points, respectively, before treatment. The values are rounded estimates from the graph.

Studied regimen300 mg of extract per day, taken as 150 mg twice daily with foodBacumen extract in capsules
Duration and population12 weeksAdults aged 40–70 with memory and attention complaints. 101 were assigned to groups and 87 completed the study (40 in the Bacumen group and 47 in the placebo group).

Comparator — placebo capsules containing microcrystalline cellulose, matched for appearance and taste

Emotional well-being — B-Lit2/4 LowRead moreCollapse
Confidence
2/4 LowRisk of bias. The analysis included only participants who completed the study. Several participants dropped out. The researchers assessed many outcomes. Replication. One trial is presented for this comparison. Studies of other extracts do not replicate this trial. Applicability. The result applies to the specified extract, population, and task. Precision. The sample was small, limiting the precision of the between-group difference. Completeness of publication. One trial is insufficient to assess whether negative results went unpublished.

The POMS-40 negative mood score decreased over 84 days by an average of 13.13 points with B-Lit and 1.76 points with placebo. The difference in change was 11.37 points. A lower score indicates better emotional well-being.

Study findings. The POMS-40 negative mood score decreased over 84 days by an average of 13.13 points with B-Lit and 1.76 points with placebo. The difference in change was 11.37 points. A lower score indicates better emotional well-being.

Studied regimen300 mg of extract per day, taken as 1 capsule in the morning after breakfastB-Lit capsule containing 300 mg of extract standardized to 30% bacosides
Duration and population84 daysAdults aged 18–60 who had experienced stress for no more than 12 weeks and had no psychiatric diagnosis. 50 were assigned to groups and 44 completed the study (23 in the B-Lit group and 21 in the placebo group).

Comparator — placebo capsule containing 500 mg of microcrystalline cellulose

Emotional well-being — Bacognize2/4 LowRead moreCollapse
Confidence
2/4 LowRisk of bias. Final questionnaires were missing for 11 of 100 participants. Emotional well-being was an additional outcome. The primary sleep outcome showed no advantage. Replication. One trial is presented for this comparison. Studies of other extracts do not replicate this trial. Applicability. The result applies to the specified extract, population, and task. Precision. The sample was small, limiting the precision of the between-group difference. Completeness of publication. One trial is insufficient to assess whether negative results went unpublished.

The SF-36 emotional well-being score rose from 69.32 to 79.20 points with Bacognize and from 71.78 to 75.67 with placebo. Scores improved by 9.88 and 3.89 points, respectively. The difference in change was 5.99 points (p=0.016).

Study findings. The SF-36 emotional well-being score rose from 69.32 to 79.20 points with Bacognize and from 71.78 to 75.67 with placebo. Scores improved by 9.88 and 3.89 points, respectively. The difference in change was 5.99 points (p=0.016).

Studied regimen150 mg of extract twice daily, morning and evening, with or without food, for a total of 300 mg/dayBacognize capsules containing a whole-plant extract made with water and alcohol, with 12% bacopa glycosides as measured by HPLC
Duration and population28-day study, with 27 days of treatment and the final questionnaire on day 27Physically healthy adults aged 18–70 with complaints of poor sleep. 100 were assigned to groups and 89 returned the final questionnaires (44 in the Bacognize group and 45 in the placebo group).

Comparator — matching placebo capsules containing microcrystalline cellulose

Sleep in adults experiencing stress — B-Lit2/4 LowRead moreCollapse
Confidence
2/4 LowRisk of bias. The analysis included only participants who completed the study. Several participants dropped out. The researchers assessed many outcomes. Replication. One trial is presented for this comparison. Studies of other extracts do not replicate this trial. Applicability. The result applies to the specified extract, population, and task. Precision. The sample was small, limiting the precision of the between-group difference. Completeness of publication. One trial is insufficient to assess whether negative results went unpublished.

The PSQI sleep problem score decreased over 84 days by an average of 3.70 points with B-Lit and 0.52 points with placebo. The difference in change was 3.18 points. A lower score indicates better sleep.

Study findings. The PSQI sleep problem score decreased over 84 days by an average of 3.70 points with B-Lit and 0.52 points with placebo. The difference in change was 3.18 points. A lower score indicates better sleep.

Studied regimen300 mg of extract per day, taken as 1 capsule in the morning after breakfastB-Lit capsule containing 300 mg of extract standardized to 30% bacosides
Duration and population84 daysAdults aged 18–60 who had experienced stress for no more than 12 weeks and had no psychiatric diagnosis. 50 were assigned to groups and 44 completed the study (23 in the B-Lit group and 21 in the placebo group).

Comparator — placebo capsule containing 500 mg of microcrystalline cellulose

Sleep in adults with insomnia complaints — Bacognize2/4 LowRead moreCollapse
Confidence
2/4 LowRisk of bias. Final questionnaires were missing for 11 of 100 participants. Emotional well-being was an additional outcome. The primary sleep outcome showed no advantage. Replication. One trial is presented for this comparison. Studies of other extracts do not replicate this trial. Applicability. The result applies to the specified extract, population, and task. Precision. The sample was small, limiting the precision of the between-group difference. Completeness of publication. One trial is insufficient to assess whether negative results went unpublished.

By day 27, scores on the BIS insomnia questionnaire decreased from 27.77 to 13.89 points with Bacognize and from 28.18 to 14.98 with placebo. Sleep improved in both groups, with no advantage detected for Bacognize.

Study findings. By day 27, scores on the BIS insomnia questionnaire decreased from 27.77 to 13.89 points with Bacognize and from 28.18 to 14.98 with placebo. Sleep improved in both groups, with no advantage detected for Bacognize.

Studied regimen150 mg of extract twice daily, morning and evening, with or without food, for a total of 300 mg/dayBacognize capsules containing a whole-plant extract made with water and alcohol, with 12% bacopa glycosides as measured by HPLC
Duration and population28-day study, with 27 days of treatment and the final questionnaire on day 27Physically healthy adults aged 18–70 with complaints of poor sleep. 100 were assigned to groups and 89 returned the final questionnaires (44 in the Bacognize group and 45 in the placebo group).

Comparator — matching placebo capsules containing microcrystalline cellulose

Sleep scores in adults without sleep disorders — B-Lit2/4 LowRead moreCollapse
Confidence
2/4 LowRisk of bias. The analysis included only participants who completed the study. Several participants dropped out. The researchers assessed many outcomes. Replication. One trial is presented for this comparison. Studies of other extracts do not replicate this trial. Applicability. The study excluded people with sleep disorders. This result describes sleep scores in participants who were healthy at baseline. Precision. The sample was small, limiting the precision of the between-group difference. Completeness of publication. One trial is insufficient to assess whether negative results went unpublished.

In adults without sleep disorders, the PSQI score decreased over 84 days by an average of 1.71 points with B-Lit and 0.06 points with placebo. The difference in change was 1.65 points. A lower score indicates better sleep.

Study findings. In adults without sleep disorders, the PSQI score decreased over 84 days by an average of 1.71 points with B-Lit and 0.06 points with placebo. The difference in change was 1.65 points. A lower score indicates better sleep.

Studied regimen300 mg of extract per day, taken as 1 capsule in the morning after breakfastB-Lit capsule containing 300 mg of extract and 90 mg of bacosides
Duration and population84 daysHealthy adults aged 18–55 without sleep disorders. 80 were assigned to groups and 74 completed the study (38 in the B-Lit group and 36 in the placebo group).

Comparator — placebo capsule containing microcrystalline cellulose

Safety and limitations

Nausea, abdominal pain, diarrhea, gas, headache, dizziness, and rash have been reported with bacopa use. In the Bacumen study, complaints, mainly digestive symptoms and headache, were more common with Bacumen than with placebo. No serious adverse reactions were reported. Pregnant and breastfeeding women were excluded from the B-Lit and Bacognize studies described here. These trials provide no basis for selecting a dose for them. The tolerability information here is limited to the preparations studied and study durations of up to 12 weeks.

The Effects of a Bacopa monnieri Extract (Bacumen®) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial ↗ · Bacopa monnieri ↗ · Effect of Bacopa monnieri Extract on Memory and Cognitive Skills in Adult Humans: A Randomized, Double-Blind, Placebo-Controlled Study ↗ · Efficacy and Safety of Bacopa monnieri Extract for Stress Management and Sleep Quality: A Randomized, Double-Blind, Placebo-Controlled Trial ↗ · Effects of a Bacopa monnieri extract (Bacognize®) on stress, fatigue, quality of life and sleep in adults with self-reported poor sleep: A randomised, double-blind, placebo-controlled study ↗

Interactions

WithEffectActionSource
CevimelineA woman taking cevimeline developed palpitations, heavy sweating, nausea, headache, and dizziness after taking a supplement containing bacopa and phosphatidylserine. It was not possible to establish what causal role, if any, bacopa specifically played in the symptoms.Discuss the supplement's ingredients with a doctor or pharmacist before combining it with cevimeline. If you develop similar symptoms, stop taking the supplement and seek medical care.Suspected cholinergic toxicity due to cevimeline hydrochloride and Bacopa monnieri interaction: a case report ↗

Food sources

Bacopa is eaten as a leafy green and added to dishes as a powder. These food studies did not establish a serving size equivalent to the studied extracts in composition and effect.

Food composition

FoodGroupAmountServingCaloriesSources
Bacopa as a leafy greenFresh greensEdible greens—A study from Assam listed Bacopa monnieri among edible leafy plants.——Mineral content of some edible medicinally important leafy vegetables of Kamrup district of Assam, India ↗
Bacopa powderDried leafy greensBacopa powder and foods made with it—Researchers analyzed dried bacopa powder as a food ingredient.——Nutrient content and total antioxidant activity in Brahmi, Moringa, Amla, dried powders and formulation of value added recipes ↗
Paratha with bacopaFlatbread with a plant ingredientBacopa powder and foods made with it—Paratha is an Indian flatbread. The study developed a version with bacopa powder.——Nutrient content and total antioxidant activity in Brahmi, Moringa, Amla, dried powders and formulation of value added recipes ↗
Soup with bacopaPrepared dishBacopa powder and foods made with it—A food study evaluated soups made with plant powders, including bacopa.——Nutrient content and total antioxidant activity in Brahmi, Moringa, Amla, dried powders and formulation of value added recipes ↗
Sandwich with bacopaPrepared dishBacopa powder and foods made with it—A food study evaluated sandwiches made with plant powders, including bacopa.——Nutrient content and total antioxidant activity in Brahmi, Moringa, Amla, dried powders and formulation of value added recipes ↗

Mineral content of some edible medicinally important leafy vegetables of Kamrup district of Assam, India ↗

Studies

PublicationWhat was studiedParticipantsForm and doseResult
Effect of Bacopa monnieri Extract on Memory and Cognitive Skills in Adult Humans: A Randomized, Double-Blind, Placebo-Controlled Study ↗Digit recall — B-Lit / Sleep scores in adults without sleep disorders — B-LitHealthy adults aged 18–55 without sleep disorders. 80 were assigned to groups and 74 completed the study (38 in the B-Lit group and 36 in the placebo group).B-Lit capsule containing 300 mg of extract and 90 mg of bacosides. Participants took 300 mg of extract per day as 1 capsule in the morning after breakfast for 84 days. The comparator was a placebo capsule containing microcrystalline cellulose.Digit recall — B-Lit. On the Digit Span test of digit sequence recall, scores rose by an average of 2.45 points with B-Lit and 0.17 points with placebo over 84 days. The difference in change was 2.28 points. Sleep scores in adults without sleep disorders — B-Lit. In adults without sleep disorders, the PSQI score decreased over 84 days by an average of 1.71 points with B-Lit and 0.06 points with placebo. The difference in change was 1.65 points. A lower score indicates better sleep.
Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial ↗Delayed word recall in older adults / Performance on a task with distracting information in older adultsIndependently living adults aged 65 and older without dementia or memory complaints. 54 were assigned to groups and 48 completed the study (24 per group).MediHerb tablet containing an extract of the above-ground parts of bacopa, with at least 50% bacosides A and B as measured by the study's method. Participants took 300 mg of extract per day as 1 tablet for 12 weeks after a 6-week placebo run-in. The comparator consisted of tablets without extract, matched for appearance, smell, and texture.Delayed word recall in older adults. After 12 weeks, participants recalled an average of 7.6 words after a delay, up from 6.4 at baseline with bacopa, and 6.9 words, up from 6.8 with placebo. The paper tested changes statistically within each group and did not report a separate estimate of the difference in change between groups. Performance on a task with distracting information in older adults. On the Stroop test, reaction time decreased from 60.1 to 57.2 seconds with bacopa and from 60.9 to 60.5 seconds with placebo. A shorter time means faster performance on the task with distracting information. The statistical test in the paper assessed change within the group.